Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Molecular therapy for Osteoporosis: Inflammatory cytokine IL-1β increases the expression of a bone formation inhibitor Sclerostin via up regulation of its target gene, 12/September/2014, 7.04 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
Significance: This study suggests, for the first time, that Inflammatory cytokine IL-1β may inhibit bone formation. Thus, pharmacological formulations encompassing “IL-1β inhibitor” may be used to treat Osteoporosis.
